Medicare Enrolled

Dr. Anamaris Ibarra

Nurse Practitioner - Family · South Miami, FL
Low-engagement
6705 S RED RD, South Miami, FL 33143
3056621160
In practice since 2016 (9 years)
NPI: 1013469766 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ibarra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ibarra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ibarra

Dr. Anamaris Ibarra is a nurse practitioner - family in South Miami, FL, with 9 years of NPI registration.

Between the years covered by Open Payments, Dr. Ibarra received a total of $10,144 from 43 pharmaceutical and/or device companies across 459 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ibarra is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice $10,144 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$10,144
Total received (2021-2024)
Avg $2,536/year across 4 years
Top 1% in FL for nurse practitioner - family
43
Companies
459
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,144 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,949
2023
$2,660
2022
$2,922
2021
$2,613

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$1,222
Novo Nordisk Inc
$1,067
Medtronic, Inc.
$922
SANOFI-AVENTIS U.S. LLC
$669
Insulet Corporation
$597
Boehringer Ingelheim Pharmaceuticals, Inc.
$466
Abbott Laboratories
$414
Amgen Inc.
$396
MannKind Corporation
$373
Tandem Diabetes Care, Inc.
$326
Zealand Pharma US, Inc.
$310
Amneal Pharmaceuticals LLC
$292
Xeris Pharmaceuticals, Inc.
$255
Bayer Healthcare Pharmaceuticals Inc.
$230
Mannkind Corporation
$217
CeQur Corporation
$192
Embecta Corp.
$189
Bayer HealthCare Pharmaceuticals Inc.
$187
AstraZeneca Pharmaceuticals LP
$186
AbbVie Inc.
$170
LifeScan, Inc.
$167
LIFESCAN, INC.
$166
Amarin Pharma Inc.
$162
ABBVIE INC.
$89
Novartis Pharmaceuticals Corporation
$84
Kyowa Kirin, Inc.
$83
Radius Health, Inc.
$79
Corcept Therapeutics
$76
Alfasigma USA, Inc.
$75
Becton, Dickinson and Company
$69
PFIZER INC.
$65
Alvogen Inc
$57
IBSA Pharma Inc.
$50
BTG International, Inc.
$40
Intuity Medical Inc
$36
Clarus Therapeutics Inc.
$31
Kowa Pharmaceuticals America, Inc.
$23
Esperion Therapeutics, Inc.
$22
GRT US Holding, Inc.
$21
Horizon Therapeutics plc
$20
NOVARTIS PHARMACEUTICALS CORPORATION
$19
VistaPharm, Inc.
$15
Tolmar, Inc.
$14
Top 3 companies account for 31.7% of total payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano 2nd Gen Pen Needle · CREON · CeQur Simplicity · Crysvita · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · InPen · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LINZESS · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCARELINK · Minimed 630G · NEXLIZET · ONETOUCH VERIO FLEX · ONETOUCH VERIO REFLECT · Omnipod · OneTouch Verio Reflect · Ozempic · PREVNAR 20 · PROCLAIM · Pogo Automatic Blood Glucose Monitoring System · Qutenza · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · SYNJARDY · SYNTHROID · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tymlos · UBRELVY · UNITHROID · V-GO DISPOSABLE INSULIN DELIVERY · VORAXAZE · Vascepa · Voraxaze · XIGDUO · ZEGALOGUE · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in FL.

Looking for a nurse practitioner - family in South Miami?
Compare family nurse practitioners in the South Miami area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
5,090
Per 100K population
189.6
County median income
$68,694
Nearest hospital
SOUTH MIAMI HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ibarra is a nurse practitioner - family, with low-engagement industry engagement in the top 1% of FL peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Ibarra receive payments from pharmaceutical companies?
Yes. Dr. Ibarra received a total of $10,144 from 43 companies across 459 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Ibarra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →